Our work provides new mechanistic insight into how MM cells use a previously undescribed receptor complex to co-opt a matrikine derived from the structural ECM protein HAPLN1 as a cancer-promoting signaling element. The gene discussed is HAPLN1; the disease is Miyoshi myopathy.